Overview
Psychoactive substance dependence, exemplified by "magic mushroom" (psilocybin mushroom) use, involves compulsive use despite harmful consequences, characterized by perceptual and affective disturbances 12.Diagnosis
Clinical Features: Mydriasis, hyperreflexia, perceptual disturbances, and affective changes 1.
History and Physical: Detailed history of substance use patterns and physical examination focusing on neurological status 12.
Laboratory Tests: Not typically required for diagnosis but may include toxicology screens to rule out other substances 1.Management
Supportive Care: Monitoring and supportive management for acute symptoms, including hydration and safety precautions 12.
Psychological Support: Counseling and psychological support to address underlying issues and prevent relapse 2.
No Specific Pharmacological Treatment: No specific pharmacological antidotes for psilocybin intoxication; treatment is largely supportive 1.Special Populations
Awareness and Education: Special emphasis on educating participants, particularly in areas where mushrooms are abundant (e.g., parts of Wales), about potential dangers and sequelae 2.Key Recommendations
Educate Participants: Increase awareness among festival attendees and communities about the risks associated with magic mushroom use to mitigate harm 2 (Evidence: Expert opinion).
Supportive Monitoring: Implement supportive monitoring and care protocols for individuals experiencing acute intoxication to ensure safety and manage symptoms 1 (Evidence: Weak).
Psychosocial Interventions: Offer psychosocial interventions and counseling to address substance use dependence and reduce relapse risk 2 (Evidence: Expert opinion).References
1 Peden NR, Bissett AF, Macaulay KE, Crooks J, Pelosi AJ. Clinical toxicology of "magic mushroom" ingestion. Postgraduate medical journal 1981. link
2 Harries AD, Evans V. Sequelae of a 'magic mushroom banquet'. Postgraduate medical journal 1981. link